Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

19/06/2014 ALBA synchrotron welcomes the one thousandth researcher 12/06/2014 € 1.365 billion of foreign investment in the Catalan industry in 2013 03/06/2014 Barcelona Synchroton Park booth at the BioKorea 2014 exhibition in Seoul 27/05/2014 The new Barcelona Synchrotron Park bus shuttle completes its first six months 20/05/2014 SENER opens in the Barcelona Synchrotron Park its new corporate headquarters in Catalonia 15/05/2014 MATGAS, Air Products' leading R&D centre worldwide
40 41 42 43 44 45 46 47 48 49